Founded in 2015, North Peak Capital Management is a New York-based hedge fund managed by Jeremy Kahan and Michael Kahan. Specializing in long/short equity strategies, the firm focuses on small and mid-cap public equities. North Peak maintains a concentrated, long-bias portfolio, emphasizing undervalued small and mid-cap companies poised to enhance shareholder capital over the medium term.
Michael Kahan is a Managing Partner at North Peak, where he co-founded the predecessor entity initially focused on private equity investments. He shifted his focus to public equity investing upon launching the long-short equity fund with his brother Jeremy in 2015. Mr. Kahan continues to serve on the Board of Directors of Extend Fertility. Before founding North Peak’s predecessor, he held the position of Director at Onex Corporation, Canada’s leading private equity firm, and before that, he worked as a management consultant at McKinsey & Company. Mr. Kahan earned an M.B.A. from Harvard Business School and graduated magna cum laude with a B.A. in Economics from Harvard University.
Jeremy Kahan serves as Managing Partner at North Peak Capital Management, LLC. Before co-founding North Peak, Mr. Kahan held the role of founding analyst at Bow Street, an opportunistic event-driven fund seeded by Blackstone. Before his tenure at Bow Street, he worked as an Associate in the Private Equity Group at MSD Capital, managing the capital of Michael Dell and his family. Earlier, Mr. Kahan served as a Senior Associate in the Transaction Services Strategy Group at PricewaterhouseCoopers. He holds an M.B.A. from Harvard Business School and graduated cum laude with a B.A. in Political Science from Yale University.
North Peak Capital Management is a hedge fund managing $1,873,800,000 in discretionary assets under management as reported in their Form ADV dated March 2024. Their Q1 2024 13F filing revealed $899,769,172 in managed 13F securities, with a concentrated top 10 holdings representing 100%. The firm's largest position is in Hilton Grand Vacations Inc., holding 5,984,587 shares.
